#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Atopic keratoconjunctivitis Rhabdomyosarcoma recurrent Gastroenteropancreatic neuroendocrine tumour disease T-cell type acute leukaemia Cerebral arteriovenous malformation haemorrhagic Immunoglobulin G4 related disease Urethral valves Heavy menstrual bleeding Synovial sarcoma metastatic Pulmonary sarcoidosis Bile acid synthesis disorder Pleural mesothelioma malignant Small intestine adenocarcinoma Squamous cell carcinoma of the vulva Juvenile psoriatic arthritis More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Basic Information Mitochondrial myopathy Hereditary angioedema – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Atypical haemolytic uraemic syndrome Stevens-Johnson syndrome – Diagnostics Uterine leiomyosarcoma – Trials in Disease Anaplastic thyroid cancer – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Treatment Osteosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluorometholone Cldn6 Rna-Lpx Tamoxifen Brinzolamide LY3841136 SODIUM Mebendazole Secukinumab Taldefgrobep Alfa Gemcitabine Hydrochloride Methotrexate Tebentafusp Eletriptan VERT-002 Telisotuzumab Vedotin Azetukalner Aluminium Hydroxide Ginisortamab HYDROMORPHONE HYDROCHLORIDE Doxycycline Fluoxetine More therapies…

    Learn about Your Condition

    Tendon injury Tooth loss Cardiac failure acute Psoriatic arthropathy Delayed graft function Herpes simplex reactivation Adenomatous polyposis coli Cluster headache Ear discomfort Paget's disease of the vulva Back pain Viral infection Eyelid ptosis Colon cancer stage III Stevens-Johnson syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Amyotrophic lateral sclerosis

  • Study on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Muscle Specific Kinase
    Belgium Denmark France The Netherlands Sweden

  • Study of Lithium Treatment for Patients with Amyotrophic Lateral Sclerosis (ALS) to Evaluate Survival Rate

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Belgium The Netherlands Spain Sweden

  • Study on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • H-L-Tryphophanyl-L-Seryl-Glycyl-L-Tryptophanyl-L-Seryl-L-Seryl-L-Cysteinyl-L-Seryl-L-Arginyl-L-Seryl-L-Cysteinyl-Glycyl-Oh (Disulfide Bond), Acetate Salt
    • Glucose
    France

  • Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

    Not recruiting

    2 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Utreloxastat
    Belgium Czechia France Germany Ireland Italy +5

  • Study on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Investigated Drugs:
    • Anti-(Misfolded Human Superoxide Dismutase 1) Human Igg1M3 Monoclonal Antibody
    Sweden

  • Study on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Phenylbutyrate
    • Ursodoxicoltaurine
    Belgium France Germany Ireland Italy The Netherlands +4
Previous Page
1 … 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!